# Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease

> **NCT01599702** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 21 (actual)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Iron Isomaltoside 1000

## Key facts

- **NCT ID:** NCT01599702
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599702, "Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01599702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*